Works citing this work

2 works

Work: Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

1. Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment

   Saade Abdalkareem Jasim, I.M. Farber, Sara Abdalrazzaq M. Noraldeen +7

   ArticleAngiogenesis and VEGF in CancerMicrovascular Research20240 citations

   ABIABI:AkademIndex/openalex/2024.article.003439

2. Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

   Qamar Abuhassan, Ghaleb Oriquat, R. Roopashree +5

   ArticleInflammasome and immune disordersTissue and Cell20260 citations

   ABIABI:AkademIndex/openalex/2026.article.002974